Description
LY-3177833 is an inhibitor of Cdc7, a therapeutic target for some cancers. It slows tumor growth in human colorectal adenocarcinoma cell lines in vitro.
Product Unit Size | Cost | Quantity | Stock |
---|
LY-3177833 is an inhibitor of Cdc7, a therapeutic target for some cancers. It slows tumor growth in human colorectal adenocarcinoma cell lines in vitro.
Cas No. | 1627696-51-8 |
---|---|
Purity | ≥99% |
Formula | C16H12FN5O |
Formula Wt. | 309.30 |
Chemical Name | LY-3177833 |
IUPAC Name | (3R)-3-(5-Fluoro-4-pyrimidinyl)-3-methyl-6-(1H-pyrazol-4-yl)-1-isoindolinone |
Synonym | LY 3177833, LY3177833 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Cheng A., Lo Y., et al. Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach. EBioMedicine. 36:241-251 (2018). PMID: 30293817.
Caffeic acid ester found in Melissa, Salvia, an...
Phytoestrogen found in various plant sources; E...
DNA alkylator.
Fermentation impurity
Synthetic non-steroid endocrine disrupter; ER a...
Endogenous peptide, involved in stress signalin...
ALK inhibitor.
FIASMA, histamine H1 inverse agonist, 5-HT2A, D...
Ca2+-sensing receptor antagonist.
Fluoroquinolone; topoisomerase IV and bacterial...
Antimicrobial peptide found in amphibians.
Nucleoside (guanosine) analog; DNA chain termin...
RXR agonist.
ITC, erysolin analog.
Dipeptide ester, commercial sweetener.
Actinomycin derivative used to study apoptosis ...
FGFR inhibitor.
Endogenous NMDA receptor antagonist.
Sphingosine 1-phosphate antagonist.
B-Raf and c-Raf inhibitor.